[] [Description of rights of each class of securities Class A Ordinary Shares Type and Class of Securities (Item 9.A.5 of Form 20-F) Each Class A ordinary share has a par value of US$0.0001 per share. The number of Class A ordinary shares that have been issued as of the last day of the financial year]
[Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development BEIJING, May 22, 2020 -- (BUSINESS WIRE) -- Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction in which Advantech C]
[] [Description of rights of each class of securities Class A Ordinary Shares Type and Class of Securities (Item 9.A.5 of Form 20-F) Each Class A ordinary share has a par value of US$0.0001 per share. The number of Class A ordinary shares that have been issued as of the last day of the financial year]
[Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development BEIJING, May 22, 2020 -- (BUSINESS WIRE) -- Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction in which Advantech C]
